{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:18:31Z","timestamp":1783052311302,"version":"3.54.6"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HR16C0001"],"award-info":[{"award-number":["HR16C0001"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.trsl.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T14:29:25Z","timestamp":1778423365000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective inhibition of STAT3 transcriptional activity by novel small molecules alleviates the development of lupus in mice"],"prefix":"10.1016","volume":"293","author":[{"given":"Mi-Sun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook-Young","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ho","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hee","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeung-Whan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-393X","authenticated-orcid":false,"given":"Chang-Hee","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2026.05.002_bib0001","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(14)60128-8","article-title":"Systemic lupus erythematosus","volume":"384","author":"Lisnevskaia","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.05.002_bib0002","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","article-title":"Systemic lupus erythematosus","volume":"369","author":"D'Cruz","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2026.05.002_bib0003","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","article-title":"Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus","volume":"27","author":"Chun","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5096741","article-title":"IL-1\u03b2 and IL-6 are highly expressed in RF+IgE+ systemic lupus erythematous subtype","volume":"2017","author":"Wu","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.trsl.2026.05.002_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/ard.2004.022681","article-title":"Raised levels of interleukin 6 in systemic lupus erythematosus correlate with anaemia","volume":"64","author":"Ripley","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2026.05.002_bib0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar2341","article-title":"The role of tumor necrosis factor-alpha in systemic lupus erythematosus","volume":"10","author":"Aringer","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.trsl.2026.05.002_bib0008","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0009","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.trsl.2026.05.002_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/biomedicines8120559","article-title":"Cytokines and transgenic matrix in autoimmune diseases: similarities and differences","volume":"8","author":"Szewczak","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.trsl.2026.05.002_bib0011","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2026.05.002_bib0012","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173107","article-title":"Targeting STAT3 in cancer and autoimmune diseases","volume":"878","author":"Gharibi","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0014","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.trsl.2026.05.002_bib0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10067-019-04467-8","article-title":"Upregulated expression of STAT3\/IL-17 in patients with systemic lupus erythematosus","volume":"38","author":"Chen","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0016","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s10067-014-2656-5","article-title":"Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy","volume":"33","author":"Wen","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0017","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124575","article-title":"Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients","volume":"4","author":"Slight-Webb","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2026.05.002_bib0018","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2011-11-392985","article-title":"Functional STAT3 deficiency compromises the generation of human T follicular helper cells","volume":"119","author":"Ma","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2026.05.002_bib0019","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.05.002_bib0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.clim.2015.04.004","article-title":"Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL\/lpr mice","volume":"158","author":"Edwards","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0021","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1177\/0961203319877242","article-title":"T cell-specific STAT3 deficiency abrogates lupus nephritis","volume":"28","author":"Yoshida","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.trsl.2026.05.002_bib0022","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2005-07-2871","article-title":"Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells","volume":"107","author":"Fornek","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2026.05.002_bib0023","article-title":"STAT3-mediated allelic imbalance of novel genetic variant Rs1047643 and B-cell-specific super-enhancer in association with systemic lupus erythematosus","volume":"11","author":"Zhang","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.trsl.2026.05.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000611","article-title":"Metformin improves renal injury of MRL\/lpr lupus-prone mice via the AMPK\/STAT3 pathway","volume":"9","author":"Chen","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.trsl.2026.05.002_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2018.05.207","article-title":"S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL\/lpr mice","volume":"503","author":"Du","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2026.05.002_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.675542","article-title":"Tofacitinib ameliorates lupus through suppression of T cell activation mediated by TGF-beta type I receptor","volume":"12","author":"Yan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0027","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12967-021-02760-2","article-title":"Niclosamide suppresses the expansion of follicular helper T cells and alleviates disease severity in two murine models of lupus via STAT3","volume":"19","author":"Jang","year":"2021","journal-title":"J Transl Med"},{"key":"10.1016\/j.trsl.2026.05.002_bib0028","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41401-021-00773-7","article-title":"Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells","volume":"43","author":"Du","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.trsl.2026.05.002_bib0029","article-title":"Inflammatory cytokines in systemic lupus erythematosus","volume":"2011","author":"Ohl","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312764","article-title":"Toll-like receptor signaling inhibitory peptide improves inflammation in animal model and human systemic lupus erythematosus","volume":"22","author":"Baek","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2026.05.002_bib0031","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5858\/133.2.233","article-title":"Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications","volume":"133","author":"Seshan","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.trsl.2026.05.002_bib0032","first-page":"658","article-title":"FDA approves AstraZeneca's anifrolumab for lupus","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.trsl.2026.05.002_bib0033","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.3928\/19382359-20220118-01","article-title":"Biologic agents and other emerging therapies for childhood SLE","volume":"51","author":"Soybilgic","year":"2022","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.trsl.2026.05.002_bib0034","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.05.002_bib0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.autrev.2017.09.006","article-title":"The new targeted therapy in systemic lupus erythematosus: is the glass half-full or half-empty?","volume":"16","author":"Doria","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2026.05.002_bib0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41584-018-0133-2","article-title":"New therapeutic strategies in systemic lupus erythematosus management","volume":"15","author":"Gatto","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.655100","article-title":"What's new in the treatment of systemic lupus erythematosus","volume":"8","author":"Liossis","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.trsl.2026.05.002_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2026.05.002_bib0039","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/art.39706","article-title":"Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity","volume":"68","author":"Slight-Webb","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0040","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/cells8080898","article-title":"Pathogenic and therapeutic relevance of JAK\/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition with an oral agent","volume":"8","author":"Alunno","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.trsl.2026.05.002_bib0041","article-title":"Cryptococcus neoformans infection induces IL-17 production by promoting STAT3 phosphorylation in CD4(+) T cells","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0042","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clim.2017.07.004","article-title":"The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus","volume":"183","author":"Xu","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0043","first-page":"516","article-title":"T follicular helper cells, interleukin-21 and systemic lupus erythematosus","volume":"56","author":"Gensous","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.trsl.2026.05.002_bib0044","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","article-title":"A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis","volume":"586","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2026.05.002_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109095","article-title":"Advance in bone destruction participated by JAK\/STAT in rheumatoid arthritis and therapeutic effect of JAK\/STAT inhibitors","volume":"111","author":"Hu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0046","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.trsl.2026.05.002_bib0047","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.07003","article-title":"Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism","volume":"7","author":"Jetten","year":"2009","journal-title":"Nucl Recept Signal"},{"key":"10.1016\/j.trsl.2026.05.002_bib0048","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.celrep.2017.05.013","article-title":"Genome-wide analysis of STAT3-mediated transcription during early human Th17 cell differentiation","volume":"19","author":"Tripathi","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.trsl.2026.05.002_bib0049","article-title":"The multifaceted role of Th1, Th9, and Th17 cells in immune checkpoint inhibition therapy","volume":"12","author":"Lee","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0051","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.kint.2021.01.024","article-title":"A multicenter blinded preclinical randomized controlled trial on Jak1\/2 inhibition in MRL\/MpJ-Fas(lpr) mice with proliferative lupus nephritis predicts low effect size","volume":"99","author":"Lei","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2026.05.002_bib0052","article-title":"Clinical outcomes observed among biopsy proven lupus nephritis patients treated with mycophenolate mofetil as first-line therapy","volume":"9","author":"Timlin","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.trsl.2026.05.002_bib0053","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","article-title":"Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis","volume":"279","author":"Clynes","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.trsl.2026.05.002_bib0054","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2026.05.002_bib0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","volume":"27","author":"Wandstrat","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2026.05.002_bib0056","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0961203319826695","article-title":"Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1","volume":"28","author":"Gasparin","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.trsl.2026.05.002_bib0057","doi-asserted-by":"crossref","first-page":"114","DOI":"10.11604\/pamj.2017.27.114.5981","article-title":"Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study","volume":"27","author":"Ahmed","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.trsl.2026.05.002_bib0058","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12519-019-00302-x","article-title":"Analysis of clinical manifestations and treatment in 26 children with fibrodysplasia ossificans progressiva in China","volume":"16","author":"Zhang","year":"2020","journal-title":"World J Pediatr"},{"key":"10.1016\/j.trsl.2026.05.002_bib0059","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1186\/ar586","article-title":"Complement and systemic lupus erythematosus","volume":"3","author":"Walport","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1016\/j.trsl.2026.05.002_bib0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2015.00475","article-title":"Mechanisms of kidney injury in lupus nephritis\u2013the role of anti-dsDNA antibodies","volume":"6","author":"Yung","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2026.05.002_bib0061","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.autrev.2007.12.001","article-title":"Anti-DNA antibodies in the pathogenesis of lupus nephritis\u2013the emerging mechanisms","volume":"7","author":"Yung","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.trsl.2026.05.002_bib0062","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1093\/ndt\/gfn314","article-title":"Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis","volume":"23","author":"Arakawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trsl.2026.05.002_bib0063","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2026.05.002_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262411981","article-title":"Selective STAT3 allosteric inhibitors HCB-5300 and HCB-5400 alleviate dextran sulfate sodium-induced ulcerative colitis in mice","volume":"26","author":"Baek","year":"2025","journal-title":"Int J Mol Sci"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524426000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:37:34Z","timestamp":1783049854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524426000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":63,"alternative-id":["S1931524426000897"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2026.05.002","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inhibition of STAT3 transcriptional activity by novel small molecules alleviates the development of lupus in mice","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}